FDA Approved: TRUDHESA — Original Application (Impel Pharmaceuticals LLC)

View source ↗

Summary

FDA approved TRUDHESA (dihydroergotamine mesylate) from Impel Pharmaceuticals as an original NDA submission for acute treatment of migraine. This marks the intr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• TRUDHESA (dihydroergotamine mesylate)

Snippet

ORIG AP for TRUDHESA (DIHYDROERGOTAMINE MESYLATE)